Regulation of the Immune System in Response to the Treatment With Tocilizumab in RA Patients
Phase of Trial: Phase IV
Latest Information Update: 16 Nov 2016
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Biomarker; Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 10 Nov 2016 Status changed from recruiting to completed.
- 13 Apr 2015 Planned End Date changed from 1 May 2014 to 1 Oct 2015, according to ClinicalTrials.gov record.